Prof. Dorothy Mbori-Ngacha reflects on the early years of HIV/AIDS in Kenya, marked by stigma and a lack of effective treatment, and how social isolation worsened the epidemic.
She discusses the introduction of Nevirapine in 2003, which reduced mother-to-child transmission by 50%, offering hope to Kenyan mothers.
Prof. Mbori-Ngacha also explores how international support, particularly from PEPFAR, revolutionized Kenya’s HIV response, improving pediatric care, education, and community-based interventions.
She addresses ongoing barriers to HIV care for key populations and outlines Kenya’s commitment to the UNAIDS 95-95-95 targets and “Triple Elimination” goals in the fight for an AIDS-free generation by 2030.
